Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk. Issue 3 (13th March 2020)

• Record Type: Journal Article
• Authors: Huang, Li; Wang, Lunwen
• Is Part Of: Bioscience reports. Volume 40:Issue 3(2020)
• Publication Date: 2020-03-13
• Subjects: meta-analysis -- polycystic ovary syndrome -- polymorphism -- VEGF; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20191691
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: Vascular endothelial growth factor ( VEGF ) plays a critical role in ovarian folliculogenesis and normal reproductive function. So far, several studies focusing on association between VEGF gene polymorphisms and polycystic ovary syndrome (PCOS). However, above association between the VEGF gene polymorphisms and PCOS susceptibility is uncertain. Hence, we performed a timely meta-analysis containing all current publications to make clear this relationship. We searched articles from the PubMed, Embase and Chinese language (WanFang and CNKI) databases that were published up until May 10, 2019. Finally, we obtained 9 studies, containing 29 case–control studies and 11 different polymorphisms. The odds ratios (OR) and 95% confidence intervals (CI) were revealed association strengths. There were significantly decreased associations between rs2010963 (-634), +9812, +405 polymorphisms and PCOS risk. Nevertheless, there existed increased associations between rs699947 (-2578), rs833061, rs1570360 (-1154), rs3025020, rs3025039 polymorphisms and PCOS susceptibility. Our current analysis suggested VEGF gene polymorphisms may be associated with PCOS risk, which is possible to be expected to become biomarkers of early detection for women.